Guest guest Posted June 6, 2011 Report Share Posted June 6, 2011 http://www.cancernetwork.com/conference-report/asco2011-hematology/content/artic\ le/10165/1867765 Free, but tedious, registration is needed to view entire interview. She mainly discusses CAL-101 and PCI-32765. It's an interesting interview, especially to get her take on these two newer drugs. She discusses first-line treatment with them. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.